Trexler Christa L, Odell Aaron T, Jeong Mark Y, Dowell Robin D, Leinwand Leslie A
From the Department of Molecular, Cellular, and Developmental Biology, BioFrontiers Institute, University of Colorado at Boulder (C.L.T., A.T.O., R.D.D., L.A.L.); and Division of Cardiology, School of Medicine, Anschutz Medical Campus, University of Colorado, Aurora (M.Y.J.).
Circ Cardiovasc Genet. 2017 Oct;10(5). doi: 10.1161/CIRCGENETICS.117.001770.
Although cardiovascular disease is the primary killer of women in the United States, women and female animals have traditionally been omitted from research studies. In reports that do include both sexes, significant sexual dimorphisms have been demonstrated in development, presentation, and outcome of cardiovascular disease. However, there is little understanding of the mechanisms underlying these observations. A more thorough understanding of sex-specific cardiovascular differences both at baseline and in disease is required to effectively consider and treat all patients with cardiovascular disease.
We analyzed contractility in the whole rat heart, adult rat ventricular myocytes (ARVMs), and myofibrils from both sexes of rats and observed functional sex differences at all levels. Hearts and ARVMs from female rats displayed greater fractional shortening than males, and female ARVMs and myofibrils took longer to relax. To define factors underlying these functional differences, we performed an RNA sequencing experiment on ARVMs from male and female rats and identified ≈600 genes were expressed in a sexually dimorphic manner. Further analysis revealed sex-specific enrichment of signaling pathways and key regulators. At the protein level, female ARVMs exhibited higher protein kinase A activity, consistent with pathway enrichment identified through RNA sequencing. In addition, activating the protein kinase A pathway diminished the contractile sexual dimorphisms previously observed.
These data support the notion that sex-specific gene expression differences at baseline influence cardiac function, particularly through the protein kinase A pathway, and could potentially be responsible for differences in cardiovascular disease presentation and outcomes.
尽管心血管疾病是美国女性的首要杀手,但传统上女性和雌性动物一直被排除在研究之外。在那些确实纳入了两性的报告中,心血管疾病的发生、表现和转归中已证实存在显著的性别差异。然而,对于这些观察结果背后的机制却知之甚少。为了有效地诊治所有心血管疾病患者,需要更全面地了解基线状态下以及疾病状态下特定性别的心血管差异。
我们分析了大鼠两性的全心脏、成年大鼠心室肌细胞(ARVM)和肌原纤维的收缩性,并在各个水平观察到了功能性性别差异。雌性大鼠的心脏和ARVM表现出比雄性更大的缩短分数,并且雌性ARVM和肌原纤维舒张所需时间更长。为了确定这些功能差异背后的因素,我们对雄性和雌性大鼠的ARVM进行了RNA测序实验,鉴定出约600个基因以性别二态性方式表达。进一步分析揭示了信号通路和关键调节因子的性别特异性富集。在蛋白质水平上,雌性ARVM表现出更高的蛋白激酶A活性,这与通过RNA测序确定的通路富集一致。此外,激活蛋白激酶A通路可减少先前观察到的收缩性性别差异。
这些数据支持这样一种观点,即基线状态下特定性别的基因表达差异会影响心脏功能,特别是通过蛋白激酶A通路,并且可能是心血管疾病表现和转归差异的原因。